A study on walnut consumption compares different components of the nut.
By Robby Gardner, Associate Editor
Walnuts may improve heart health beyond just lowering cholesterol, say U.S. researchers. By preparing different components of walnuts for consumption, researchers were able to pinpoint different vascular effects of walnut based on the type of product consumed: the whole nut, the skin, the defatted meal, or the oil.
In crossover fashion, 15 human subjects with high cholesterol ate one of the four walnut products. Blood readings were taken at baseline and post-walnut consumption (30 minutes, 1 hour, 2 hours, 4 hours, and 6 hours), and results differed from product to product. Antioxidant capacity improved with walnut oil and skin, but the oil was the only product capable of maintaining endothelial function, the ability of blood vessels to contract. Whole walnuts, which contain the oil, increased the removal of excess cholesterol from the body.
Walnuts are rich sources of omega-3 ALA, gamma-tocopherol, and plant sterols, and these nutrients are all present in the oil. The apparent cardiovascular benefits of walnuts now appear more tied to walnut oil than any other part of the walnut.
The California Walnut Commission funded this study, now published in The Journal of Nutrition.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.